What does a ferritin level of 11 ng/mL indicate and how should iron deficiency be evaluated and treated?

Severe Iron Deficiency Requiring Immediate Evaluation and Treatment

A ferritin of 11 ng/mL confirms absolute iron deficiency with 99% specificity and mandates immediate oral iron supplementation plus urgent investigation to identify the underlying cause of iron loss. 1

Diagnostic Confirmation

Your ferritin level falls well below the diagnostic threshold of <15 ng/mL, which definitively confirms depleted iron stores 1. This degree of depletion indicates:

• Absolute iron deficiency is present—no additional testing is needed to confirm the diagnosis 1
• Calculate transferrin saturation (TSAT) using the formula: (serum iron × 100) ÷ total iron binding capacity; expect TSAT <16-20%, which confirms impaired iron delivery to bone marrow 1
• Check complete blood count to assess whether microcytic anemia (low MCV, low MCH) has developed yet 1

Immediate Treatment Protocol

Start oral iron supplementation today without waiting for investigation results:

• Ferrous sulfate 65 mg elemental iron daily (or 60-65 mg every other day) is first-line therapy 2, 3
• Alternate-day dosing improves absorption by 30-50% and reduces gastrointestinal side effects (nausea, constipation, diarrhea) compared to daily dosing 1
• Take on an empty stomach for optimal absorption, or with meals if gastrointestinal symptoms occur 1
• Expected response: hemoglobin should rise by ≥10 g/L within 2 weeks of starting therapy 1, 3

Mandatory Investigation of Underlying Cause

The severity of your iron deficiency demands urgent evaluation for the source of iron loss:

For Adult Men and Postmenopausal Women:

• Bidirectional endoscopy (upper gastroscopy + colonoscopy) is mandatory because iron deficiency may be the sole manifestation of gastrointestinal malignancy 1, 2, 3

For Premenopausal Women:

• Screen for celiac disease with tissue transglutaminase IgA antibodies; celiac disease accounts for 3-5% of iron-deficiency cases and causes treatment failure when missed 1, 2
• Test for Helicobacter pylori infection (stool antigen or urea-breath test) because the organism impairs iron absorption 1, 2
• Assess menstrual blood loss history as heavy or prolonged menstruation is the most common cause in this population 2
• Reserve bidirectional endoscopy for: age ≥50 years, gastrointestinal symptoms (abdominal pain, altered bowel habits, visible blood), positive celiac or H. pylori tests, lack of response to oral iron after 8-10 weeks, or strong family history of colorectal cancer 1

When to Switch to Intravenous Iron

Intravenous ferric carboxymaltose (15 mg/kg, maximum 1000 mg per dose) is indicated when any of the following apply 1, 2:

• Severe oral iron intolerance (marked nausea, constipation, diarrhea)
• Confirmed malabsorption (celiac disease, inflammatory bowel disease, post-bariatric surgery)
• Ongoing blood loss exceeding oral replacement capacity
• Chronic inflammatory conditions (chronic kidney disease, heart failure, cancer)
• Pregnancy in second/third trimester
• Lack of hemoglobin response after 8-10 weeks of adequate oral iron

IV iron produces reticulocytosis within 3-5 days and yields a mean hemoglobin increase of ≈8 g/L over 8 days, demonstrating superior efficacy in these populations 1.

Follow-Up and Monitoring

• Repeat CBC and ferritin at 8-10 weeks to assess response to treatment 1, 3
• Target ferritin >100 ng/mL to fully restore iron stores and prevent recurrence 1
• Continue oral iron for 3 months after hemoglobin normalizes because absorbed iron is preferentially used for red-cell production first, and storage compartments refill only after hemoglobin corrects 1
• Persistent failure of ferritin to rise despite adequate supplementation signals ongoing blood loss or malabsorption and warrants urgent gastrointestinal evaluation 1

Critical Pitfalls to Avoid

• Do not delay treatment while awaiting investigation results; iron supplementation should begin immediately 1
• Do not discontinue iron therapy once hemoglobin normalizes; an additional 3 months of supplementation is required for ferritin to reach >100 ng/mL 1
• Do not overlook celiac disease screening given its 3-5% prevalence among iron-deficiency cases; missing this diagnosis leads to treatment failure 1
• Do not delay endoscopic evaluation in high-risk patients (age ≥50, alarm symptoms, treatment failure), as gastrointestinal malignancy can present solely with iron deficiency 1

Long-Term Management

For individuals at risk of recurrent iron depletion (menstruating females, vegetarians, endurance athletes), schedule ferritin screening every 6-12 months to detect early depletion before anemia develops 1. However, do not continue daily iron supplementation once ferritin normalizes, as this is potentially harmful 1, 4.